✦ LIBER ✦

Assessment of Simplified Methods to Measure 18F-FLT Uptake Changes in EGFR-Mutated Non-Small Cell Lung Cancer Patients Undergoing EGFR Tyrosine Kinase Inhibitor Treatment

✍ Scribed by Frings, V.; Yaqub, M.; Hoyng, L. L.; Golla, S. S. V.; Windhorst, A. D.; Schuit, R. C.; Lammertsma, A. A.; Hoekstra, O. S.; Smit, E. F.; Boellaard, R.

Book ID: 127265915
Publisher: The Society of Nuclear Medicine
Year: 2014
Tongue: English
Weight: 881 KB
Volume: 55
Category: Article
ISSN: 0161-5505
DOI: 10.2967/jnumed.114.140913

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epidermal growth factor receptor (EGFR)

Epidermal growth factor receptor (EGFR) mutations in a series of non-small-cell lung cancer (NSCLC) patients and response rate to EGFR-specific tyrosine kinase inhibitors (TKIs)

✍ Elena María Martínez-Navarro; Joseba Rebollo; Ramón González-Manzano; Manuel Sur 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 230 KB

PCN109 Cost Effectiveness of First Line

PCN109 Cost Effectiveness of First Line Tyrosine Kinase Inhibitor Treatment in Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Markov Model

✍ Borget, I.; Vergnenegre, A.; Chouaid, C. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB